Recombinant follicle stimulating hormone - Intas Pharmaceuticals

Drug Profile

Recombinant follicle stimulating hormone - Intas Pharmaceuticals

Alternative Names: Folisurge; Follicle stimulating hormone - Intas Pharmaceuticals; FSH -Intas Pharmaceuticals

Latest Information Update: 05 Feb 2014

Price : $50

At a glance

  • Originator Intas Pharmaceuticals
  • Class Follicle stimulating hormones; Infertility therapies; Pituitary gonadotropins
  • Mechanism of Action Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Female infertility

Most Recent Events

  • 31 Dec 2013 Launched for Female infertility in India (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top